American Society of Addiction Medicine
American Society of Addiction Medicine
Lead: Signaling-specific inhibition of the CB1 receptor for cannabis use disorder
Lead: Signaling-specific inhibition of the CB1 receptor for cannabis use disorder
Lead: Signaling-specific inhibition of the CB1 receptor for cannabis use disorder
Tuesday 20th June 2023
Stay informed with the latest breakthroughs in addiction treatment, from cannabis use disorder therapies to wearable tech predictions.
7 minutes
Informative
Empowering
Hopeful
Transformative
Supportive
About this podcast
Author:
American Society of Addiction Medicine
Overview:
Categories:
Innovative Treatments & Recovery Paths
Navigating Alcohol Dependency
Family Recovery from Addiction
Nutritional Pathways to Recovery
Navigating Intimate Relationships
Links:
Visit site
Episodes:
140 (View all)
Do you want to link to this podcast?
Get the buttons here!Pioneering Treatments and Insights in Addiction Medicine: A Weekly Update
Episode Overview
- AEF-0117 shows promising results as a treatment for cannabis use disorder
- Wearable devices are being used to predict drug use recurrence
- Association of ventricular arrhythmias with over-the-counter and recreational opioids
- Study on the impact of alcohol consumption on over 200 diseases in Chinese men
- Relationship between law enforcement drug seizures and changes in fatal and non-fatal overdoses
AEF-0117 is a safe and potentially efficacious treatment for cannabis use disorder.
Imagine a world where cannabis use disorder (CUD) can be treated effectively with minimal side effects. In this episode of 'This Week in Addiction Medicine', the spotlight is on AEF0117, a novel pharmacotherapy that targets the cannabinoid receptor 1 (CB1-SSi). Unlike traditional treatments, AEF0117 zeroes in on specific intracellular effects caused by THC, reducing self-administration and behavioral impairments in both animal models and human trials without triggering withdrawal symptoms. This could be a game-changer for those battling CUD.
But that's just the beginning. The episode also dives into cutting-edge research on wearable devices that predict drug use recurrence, offering a glimpse into the future of addiction monitoring. You'll also hear about the surprising link between ventricular arrhythmias and both over-the-counter and recreational opioids. Plus, there's an eye-opening discussion on how alcohol consumption impacts over 200 diseases in Chinese men.
If you're curious about the ripple effects of law enforcement drug seizures on overdose rates, this episode has got you covered. The urgent need for fentanyl research and testing is another critical topic, highlighting the ongoing battle against this potent opioid. Lastly, the role of addiction specialists in reproductive rights brings a unique perspective to the intersection of healthcare and personal choice.
Whether you're a healthcare professional, someone affected by addiction, or simply interested in the latest medical advancements, this episode offers valuable insights and practical information.